Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05626426

Electrical Stimulation for the Treatment of Optic Neuropathies

Led by Stanford University · Updated on 2025-07-08

40

Participants Needed

1

Research Sites

248 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.

CONDITIONS

Official Title

Electrical Stimulation for the Treatment of Optic Neuropathies

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant must be at least 18 years old
  • Participant must be able to follow study requirements and complete all scheduled activities
  • Clinical diagnosis consistent with glaucoma with mean deviation worse than -3 on Humphrey Visual Field 24-2 test
  • Reliable visual field test results with fixation losses and false positives below 20%
  • Eye pressure must be clinically stable as determined by the investigator
  • If both eyes qualify, the worse eye or chosen eye may be included
  • Participant must understand and sign informed consent, or have it read to them if vision impaired
Not Eligible

You will not qualify if you...

  • Unable to comply with study procedures or follow-up visits
  • History of ocular herpes zoster
  • Presence of pathological nystagmus
  • Visually significant retinopathy such as diabetic retinopathy or retinitis pigmentosa
  • Corneal opacification or lack of optical clarity
  • Uveitis or other ocular inflammatory diseases
  • Presence of electric or electronic implants like pacemakers
  • Acute conjunctivitis
  • Acute autoimmune disease
  • Pregnant or lactating individuals
  • Physical or mental conditions increasing risk or interfering with study, including dementia
  • Unresected brain tumors
  • Implanted intracranial magnetic metals not compatible with MRI (excluding dental implants and titanium plates)
  • Any skin damage
  • Children and comatose patients
  • History of epileptic seizure within the last 10 years
  • Uncontrolled systemic hypertension or diabetes
  • Unable or unwilling to travel, comply with study, or confirm follow-up
  • Participation in vision training/stimulation studies in the last 12 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Byers Eye Institute

Palo Alto, California, United States, 94303

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here